跳至主要内容
临床试验/NCT02848638
NCT02848638已完成不适用

Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization With Large Hepatocellular Carcinomas or Associated Portal Vein Thrombosis

University of Washington0 个研究点目标入组 35 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
主要终点
Degree and distribution of Y90 particle uptake

研究概览

简要总结

The primary goal of the study is to see if the PET/CT will be able to determine the precise location of the Y-90 particles within the liver and within the tumors. We hope to use this information in order to see if these particles distribute evenly throughout large tumors or if the particles go into the tumor which is located in the portal vein.

The secondary goals are threefold. First correlate the distribution of Y90 particles (as demonstrated by PET/CT) with the degree of dead-tumor tissue. Second, see if there is a difference in the Y90 particle's distribution when a low particle load (1-3 million particles) is used compared to when a high particle load (6-8 million particles) is used. Lastly, compare the sensitivity of standard imaging ( bremsstrahlung imaging) currently being used for the Yttrium-90 angioembolization procedure to the sensitivity of the pair production PET research imaging.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • UWMC patients over 18 years of age
  • Presence of hepatocellular carcinoma greater than 5 cm OR presence of tumor-associated portal vein thrombosis.
  • Currently undergoing treatment with Yttrium-90 Radioembolization
  • Able to sign informed consent

排除标准

  • Patients who are not undergoing treatment with Yttrium-90 Radioembolization
  • Patients unable to provide informed consent

结局指标

主要结局

Degree and distribution of Y90 particle uptake

时间窗: Within one year of Enrollment completion

To use pair production PET/CT in order to determine the degree and distribution of Y90 particle uptake in patients with large (\>5cm) liver tumors or patients with tumor-associated portal vein thrombosis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Siddharth A. Padia

Associate Professor

University of Washington

相似试验